Leadership
Shatterproof’s leadership team consists of doctors, executives, addiction specialists, and people affected by substance use disorders. They are committed to reversing the course of the addiction crisis in the United States.
Board of Directors
Jeffrey Assaf
Managing Director and CIO, ICG
Jonathan E. Fielding, MD
Co-Director, UCLA Center for Healthier Children, Families and Communities
Howard Finkelstein
President of Finkelstein & Co.
Gary Henson, CFA
President, Tortoise Investments
Chris Hocevar
CEO, Help at Home
Pam Jenkins
President of Global Public Affairs, Weber Shandwick
Gary Mendell
Founder and CEO
Gil Menna
Chair, Real Estate Capital Markets Group, Goodwin Proctor LLP
Russ Mitchell
co-CEO, Mitchells Stores
Dana Redd
CEO of the Rowan University/Rutgers-Camden Board of Governors
Anthony Rutledge
CEO, HEI Hotels & Resorts
Mark Waller
Managing Director, Sales and Marketing, McLaren Racing Ltd.
Ken Zimmerman
Adjunct Assistant Professor of Urban Planning, NYU’s Robert F. Wagner Graduate School of Public Service
Board of Advisors
Donald Berwick, MD, MPP
Former Administrator, Centers for Medicare and Medicaid Services; Former President & CEO, Institute for Healthcare Improvement
Christopher Carey
Executive Vice President and Chief Financial Officer, City National Bank
Thomas J. Corcoran, Jr.
TCOR Hotel Partners
Ken Goulet
Senior-Level Health Care Executive
The Honorable Patrick Kennedy
Former Congressman; Co-Founder, One Mind for Research
Jessalyn Kiesa
Manager of Digital Engagement at the National Education Association
Peter Krieger
Former President and Chief Operating Officer of Adspace Networks, Inc.
Edie Magnus
Executive Director of Media and Innovation for Mercy College
Mark G. Miller
Former Managing Director of Citigroup Global Markets and Blackrock Inc
Andrey Ostrovsky
Dr. Andrey Ostrovsky is the Chief Medical Officer and SVP of Behavioral Health at Solera Health
Maurice Reznik
CEO of Women’s Intimate Apparel for USA and Great Britain and President of the Company’s Delta Galil USA segment
Kirk Rimer
Co-head of Crow Holdings Capital Investment Partners
Andrew Rowe
CEO, AllMed Heathcare Management
Joe Smyser
CEO of The Public Good Projects (PGP)
Mark Stern
Principal, InnovationHealth
Thomas Sullivan
Philanthropy Consultant
Curtis G. Viebranz
Vice Chairman of Ole Communications
Keith Ward
Executive Director at JPMorgan Chase & Co.
Dr. Leana Wen
Emergency Physician, Public Health Leader, Advocate for Patient-Centered Healthcare Reform
Stu Zakim
Owner of Bridge Strategic Communications
Scientific Board
Amelia Arria, Ph.D.
Associate Professor, Department of Behavioral and Community Health; Director, Center on Youth Adult Health and Development, University of Maryland School of Public Health
Alisa Bahl, PhD
SVP, Clinical Alliances, Magellan Health
David Calabrese
SVP and Chief Pharmacy Officer, OptumRX
Richard Catalano, PhD
Professor & Director, Social Development Research Group, University of Washington
Larry Gentilello, MD
Professor of Surgery, Adjunct Professor of Management, Policy and Community Health, University of Texas; Former President, Society for Prevention Research
Martin H. Rosenzweig, MD
Senior Behavioral Medical Director with Optum
David Hawkins, PhD
Professor & Founding Director, Social Development Research Group, University of Washington
Thomas McLellan, PhD
Founder, Treatment Research Institute
Douglas Nemecek, MD, MBA
Chief Medical Officer for Behavioral Health, Cigna
Lipi Roy, MD, MPH, FASAM
Internal Medicine Physician, MSNBC and NBC News Medical Contributor
Opioid Overdose Advisory Board
Van Ingram
Executive Director, Kentucky Office of Drug Control Policy
Andrew Kolodny, MD
Co-Director of The Opioid Policy Research Collaborative at the Heller School for Social Policy and Management
John L. Eadie
Director of the Prescription Drug Monitoring Program (PDMP) Center of Excellence at Brandeis University